Adding Bristol-Myers Squibb to my Jubak Picks Portfolio tomorrow
As I noted in my posts over the weekend, I think that along with all the general volatility and the rotation away from high moment and higher price-to-earnings ratio technology stocks, the last week or so saw a rotation into “safe” haven stocks such as...
Sell Bristol-Myers Squibb before Thursday’s earnings report
I’m selling Bristol-Myers Squibb (BMY) out of my Jubak Picks portfolio ahead of Thursday’s report of first quarter earnings. I’m afraid that earnings will confirm what monthly sales reports from Bristol-Myers and competitors have outlined: That the...
Bristol-Myers continues to make up lost ground after August failure of Opdivo trial
Back on August 8 Bristol-Myers Squibb (BMY) announced that its key immuno-oncology drug Opdivo had failed to demonstrate its efficacy in a trial for treating lung cancer. At the time I characterized this particular trial as a part of a go-for-broke strategy that would...
Bristol-Myers gambled and lost on a quick expansion of cancer drug Opdivo’s market–but there’s still good upside in the shares
Update September 21. Let’s be clear about what happened to Bristol-Myers Squibb (BMY) and its key immuno-oncology drug Opdivo on Friday, August 8, when the company announced that Opdivo had failed to demonstrate its efficacy in a trial for treating lung cancer....
Raising target price on Bristol-Myers
Update June 6. The spring/summer meeting of the American Society of Clinical Oncology is the occasion of the year for drug companies reporting new research on cancer treatments. This year Bristol-Myers Squibb (BMY) has had a great meeting with a research report...Raising target price on Bristol-Myers
Update June 6. The spring/summer meeting of the American Society of Clinical Oncology is the occasion of the year for drug companies reporting new research on cancer treatments. This year Bristol-Myers Squibb (BMY) has had a great meeting with a research report...Call it "nutritionals," or nutriceuticals" or whatever–but here's how to invest in the hottest market in food
Nobody can accuse these companies of thinking short-term. Along with its third quarter earnings report on October 7 PepsiCo (PEP) announced that it was creating a new Global Nutrition Group “to deliver breakthrough innovation in the areas of fruits and vegetables,...Political passion and profitable investing don't mix
Turns out that it’s hard to invest profitably when you’re wearing political blinders. What counts in investing isn’t the world as you’d like it to be but the world as it is. Yesterday, on the day after the evening when Democrats in the House succeeded in passing the...Here we go again: Drug stocks rally but is that a reaction to merger news or a sign that investors are getting more defensive?
Last time we had a one day pull back that led some of us (okay, me) to question whether this rally was getting tired we saw the stock market as a whole go down but the drug sector move up. Now today’s strength in the sector on a down day for the market as a...Jim’s Daily Email Alerts:
Every post from Jubak Picks straight to your mailbox. And they're free!